Pfizer Inc. is nearing an agreement to buy biotech Medivation Inc. in a deal that would add one of the crown jewels of the multibillion-dollar market for cancer drugs to Pfizer’s portfolio, according to people familiar with the matter.
from WSJ.com: US Business http://ift.tt/2befxbk
via IFTTT
No comments:
Post a Comment